Type of exercise mimetics | Molecule | Compound | Beneficial effects | Therapeutic implications | Key studies |
---|---|---|---|---|---|
Myokines | Irisin | Recombinant irisin | (1) Attenuate glial activation by binding αVβ5 integrin receptor; improve spatial learning and memory (2) Decrease tau phosphorylation, α-synuclein, and inflammatory cytokine levels (3) Rescue synaptic plasticity and improve impairment in NOR and fear conditioning memory | Anti-neuroinflammation, neuronal protection and memory promotion for AD and PD | |
AMPK | Metformin | (1) Improve cognitive function (2) Reduce the risk of dementia | AD prevention and cognitive promotion for AD and PD | ||
 | AICAR | (1) Increase IDE and reduce Aβ or α-synuclein deposition; enhance spatial learning and cognitive performance (2) Inhibit neuroinflammation and promote neurite growth | Neuroinflammation inhibition, neuronal protection and cognitive improvement for AD and PD | ||
PPARδ | GW501516 | (1) Increase AHN and cognition (2) Reduce neuroinflammation | Brain health and cognitive promotion for AD | ||
Neurotrophic factor | BDNF | Recombinant BDNF, Recombinant BDNF + ADTC5, DHF | (1) Up-regulate α-secretase, ameliorate Aβ levels and increase sAPPα levels (2) Reduce α-synuclein level (3) Increase phosphorylation of TrkB and restore synaptic plasticity and memory function (4) Increase AHN and memory performance (5) Increase NG2 glial cells and EGR1 and ARC gene expression; enhance cognitive performance and NOR assessments | Neuronal protection and cognitive improvement for AD, PD, and HD | |
Noncoding RNAs | miRNAs | miRNA-132, miRNA-146, miRNA-155, miRNA-7, miRNA-21, miRNA-339, miRNA-29, miRNA-129–1-3p, miRNA-144-5p, miRNA-708-5p, miRNA-135a, miRNA-21, miRNA-34a | (1) Rescue AHN and memory impairment (2) Alleviate the accumulation of α-synuclein or Aβ and Tau hyperphosphorylation; restore AHN and cognitive function (3) Ameliorate neuroinflammation (4) Ameliorate the activation of microglial cells and neurodegeneration | Anti-neuroinflammation; brain and memory improvement for AD, PD and HD | [147, 272, 276, 277, 284, 286, 300, 306, 360,361,362,363,364,365,366] |
Methyl donor | Methylation | SAM | (1) Ameliorate AD pathology and improve cognitive function (2) Restore normal gene expression, reduce presenilin1 expression, and decrease Aβ levels。 (3) Increase secretases and ApoE expression (4) Increase GSH and decrease ROS and toxic xenobiotics (5) Prevent neuronal loss, elevate BDNF levels, and inhibit neuroinflammation | Brain health and memory promotion for AD and PD | |
Metabolism mediators | Apolipoprotein J | Clusterin | (1) Inhibit neuroinflammation, promote AHN, and improve contextual learning and memory function (2) Increase excitatory neurotransmission, reverse synaptic damage and alleviate AD pathology (3) Reduce cell apoptosis and increase neuronal differentiation | Hippocampal neurogenesis and memory improvement for AD | |
GPI | Gpld1 | Increase AHN, BDNF level, and memory function | Brain and memory promotion for AD | [37] | |
Other candidates | Gut microbiome | SCFAs | (1) Increase gut health and preserve microbiota community diversity (2) Enrich SCFAs, Firmicutes phylum (3) Decrease gut inflammation and improve cognition | Gut-brain health and cognitive improvement for AD, PD and HD | |
VEGF | SU1498 | Promote AHN and cognition | Brain health and memory promotion | ||
Serotonin | TPH2, 5-HT3 receptor, SERT | Increase neuronal proliferation and outgrowth | Brain health promotion |